SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

$SLAP is gaining attention, with community members expressing excitement and anticipation for potential gains. Sentiment revolves around the project's progress and future prospects, particularly within the Base network. The community frequently uses the terms '$BROKE', '$RAGE', and '$WAGMI', potentially indicating a shared experience of overcoming challenges and striving for success.

Monero

Monero is trending as community members discuss its potential, use cases, and status as a leading privacy coin. Recent price action and bullish chart patterns have sparked speculation about Monero's future, with some eyeing previous all-time highs, while others believe it is what Bitcoin should have been. The community is also discussing its relative stability compared to other cryptocurrencies and its importance in a world where privacy is increasingly valued.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

CVM is trending amid anticipation for a decision from the Saudi Food and Drug Authority (SFDA) regarding Breakthrough Medicine Designation for Multikine. Community discussions revolve around the potential for expedited approval and market access in Saudi Arabia, a key element of CEL-SCI's strategic roadmap. Some are expressing frustration from the long wait time, while others remain confident in the drug's potential and the partnership with Dallah Pharma.

P8BCI Is the CCM Creator Capital Markets Creator token created by Nick Wray, intended to form a community for talking about his journey with ALS, his experiences with Telepathy BCI experiments, as well as his experiences and journey through the Solana blockchain, and cryptocurrency world of Web 3. In addition to this, prior to his progression of ALS Nick was an avid drummer, a creative, and an enjoyer of philosophical discussion - and enabled now by his BCI explores creating, and in addition to sharing his story, interacting with the community forming around his experiences.

Telepath8

Telepath8 ($P8BCI) is trending as the community rallies around its developer, Nick Wray, and his work on the project. Conversations highlight Wray's background and apparent connections to Neuralink. Some community members suggest these factors are bullish for the crypto's future.

ETF Opportunities Trust - T-REX 2X Long TTD Daily Target ETF

T-REX 2X Long TTD Daily Target ETF

Traders are discussing $TTDU, a 2x leveraged ETF for $TTD, focusing on its potential for amplified gains, especially after what some consider an overreaction to earnings. Community members are weighing the risks and rewards of using leverage, with some citing technical indicators and analyst price targets as bullish signals for $TTD and, by extension, $TTDU.

Direxion Shares ETF Trust - Direxion Daily Homebuilders & Supplies Bull 3X Shares

Direxion Daily Homebuilders & Supplies Bull 3X Shares

The Direxion Daily Homebuilders & Supplies Bull 3X Shares ($NAIL) is trending amid discussions about potential interest rate cuts and their impact on the housing market. Community members are weighing the possibility of a new housing bubble and debating the ETF's future trajectory, with some pointing to technical indicators suggesting a buying opportunity. Recent data on pending home sales and building permits are also factoring into the conversation.

Concordium is the Layer-1 blockchain built for a new era of digital trust. With mandatory, privacy-preserving identity verification built into its consensus layer, utilizing zero-knowledge proof technology. Concordium also enables Protocol-level tokens that eliminate smart contract risks by being issued directly at the consensus layer, with built-in features that provide the infrastructure for compliance-ready use cases. At its core is Smart Money - programmable, identity-embedded, and compliance-ready value that powers trusted interactions across Web3. Smart Money enables frictionless exchange, automation, and verifiable trust by design. Unlike conventional blockchains, Concordium integrates trust, accountability, and privacy into its architecture from the ground up  bridging traditional systems and Web3 to build a transparent, sustainable digital future. The name Concordium comes from the Latin concordia—meaning harmony and agreement—a reflection of its mission to build infrastructure that embeds trust, privacy, and compliance into every interaction.

Concordium

Concordium ($CCD) is trending as discussions highlight its focus on compliance, privacy, and real-world utility, particularly within the PayFi sector. Community members are drawn to Concordium's unique approach to balancing privacy and transparency, suggesting it's positioning itself as a key player in regulated DeFi. The recent partnership with bitcoin.com is also driving bullish sentiment.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is trending amid mixed sentiment as investors debate its valuation, future growth, and potential for a buyout, especially following news of other acquisitions in the biotech space. Community discussions center around the company's revenue projections, profitability, and whether management will consider a deal, while others are closely watching technical indicators and potential market manipulation.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is trending following positive Phase 1 data for its CTX310 therapy, showcasing significant cholesterol and triglyceride reduction with a one-time treatment. The community is excited about the potential for a single-dose solution to lifelong lipid disorders, with some anticipating blockbuster potential and future applications in diabetes and cancer.

Mantle

Mantle is seeing volatile price action, sparking heated discussions around resistance levels and perceived manipulation. The community is closely watching for potential breakouts while reacting to news around ecosystem developments and rewards programs. Recent integrations with Chainlink and EigenLayer, coupled with new DeFi initiatives, are also driving interest in Mantle's potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Streaming Stocks To Follow Today - November 7th

Spotify Technology, Roku, Tencent Music Entertainment Group, Confluent, NetEase, Franco-Nevada, and fuboTV are the seven Streaming stocks to watch today, according to MarketBeat's stock screener...

Streaming Stocks To Keep An Eye On - November 6th

Spotify Technology, Roku, and Confluent are the three Streaming stocks to watch today, according to MarketBeat's stock screener tool. Streaming stocks are shares of companies whose primary business...

Neha Narkhede Sells 30,000 Shares of Confluent (NASDAQ:CFLT) Stock

Confluent, Inc. (NASDAQ:CFLT - Get Free Report) Director Neha Narkhede sold 30,000 shares of the stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price...

Confluent Expands Tableflow to Power Real-Time Analytics and AI Across Clouds

Confluent, Inc. (Nasdaq:CFLT), the data streaming pioneer, today announced the General Availability (GA) of Delta Lake and Databricks Unity Catalog integrations in Confluent Tableflow, along with...

Confluent Launches Confluent Private Cloud, Bringing Cloud Simplicity On-Premises

Confluent, Inc. (Nasdaq:CFLT), the data streaming pioneer, today announced Confluent Private Cloud, the simplest way to deploy, manage, and govern streaming data on private infrastructure. Confluent...

Confluent Launches Confluent Intelligence to Solve the AI Context Gap

Confluent, Inc. (Nasdaq:CFLT), the data streaming pioneer, today announced Confluent Intelligence, the fastest path to building and powering context-rich, real-time artificial intelligence (AI...

The Confluent Real-Time Context Engine: Power AI Agents and Apps With Instant Intelligence

Confluent, Inc. (Nasdaq:CFLT), the data streaming pioneer, today announced Real-Time Context Engine, a fully managed service using Model Context Protocol (MCP). The service delivers real-time...

Build AI Agents That Observe, Reason, and Act in Real Time With Confluent

Confluent, Inc. (Nasdaq:CFLT), the data streaming pioneer, today introduced new Streaming Agents advancements that make it easier to build and scale event-driven artificial intelligence (AI) agents...

Compared to Estimates, Confluent (CFLT) Q3 Earnings: A Look at Key Metrics

The headline numbers for Confluent (CFLT) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Confluent (CFLT) Q3 Earnings and Revenues Beat Estimates

Confluent (CFLT) delivered earnings and revenue surprises of +30.00% and +2.22%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Confluent, Inc. engages in creating a data infrastructure platform focused on data in motion. The firm provides application architecture engagement, multi data center, security and upgrade engagement, and Amazon web services cloud deployment services. Its products include Confluent Cloud, Confluent Platform, WarpStream BYOC, Connectors, Flink, Stream Governance, and Confluent Hub. The company was founded by Edward Jay Kreps, Neha Narkhede, and Jun Rao on September 1, 2014, and is headquartered in Mountain View, CA.

Confluent Inc - Ordinary Shares Class A

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

CFLT
Confluent Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CFLT News

CFLTConfluent Inc